Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 23, 2004
An existing licensing agreement with Angiotech Pharmaceuticals, Inc. allows Company to obtain an exclusive license for the use of paclitaxel and other agents in the coronary vascular field.
-
Nov 22, 2004
French government adds new patient categories to reimbursement approval criteria.
-
Nov 18, 2004
Company plans to use the proceeds to repay commercial paper borrowings and for other general corporate purposes.
-
Nov 16, 2004
Equity investment in a privately held company developing a balloon-expandable, bioresorbable drug-eluting stent.
-
Nov 15, 2004
The two series of senior notes will have varied maturities and a combined aggregate principal amount of $500 million.
-
Nov 12, 2004
A live webcast and replay of the November 18 conference session will be available.
-
Nov 8, 2004Boston Scientific Announces Resumption of Distribution of Advanced Bionics Cochlear Auditory Implant
Company subsidiary will resume worldwide distribution after a voluntary recall of all unimplanted cochlear implant systems.
-
Nov 5, 2004
TAXUS™ Express2™ paclitaxel-eluting coronary stent system will be the subject of 15 presentations.
-
Nov 4, 2004
A live webcast and replay of the November 10 conference session will be available.
-
Nov 2, 2004
Patients with Gastroesophageal Reflux Disease (GERD) reported substantial improvements after the Enteryx® Procedure.